Job Description

Immix Biopharma, Inc. (NADSAQ:IMMX)

 

Corporate Strategy – Senior Analyst

Location: Los Angeles, CA / Hybrid

Full time position

 

How You Will Contribute

Responsible for corporate, investor and board presentations Responsible for financial and operating models Existing Pipeline – Using literature and commercial database research, participate in determining development strategy for existing pipeline New Pipeline – Conduct literature and commercial database research to evaluate opportunities to expand pipeline of human therapeutics

 

Skills and Experience We Look For

Prior healthcare investment banking and/or equity research internship, or work experience (~1-2 years) preferred

Education: BS/BA, or MD/PhD/PharmD/science degree

 

Our 3 Core Values

Intelligence Integrity Initiative

 

Rewards at Immix

Compensation commensurate with experience. Health insurance and 401k included.

 

About Immix Biopharma, Inc.

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201. NXC-201 is being evaluated in the U.S. Phase 1b/2 trial NEXICART-2 (NCT06097832) as well as the ex-U.S. study NEXICART-1 (NCT04720313). NXC-201 has demonstrated no neurotoxicity of any kind in AL Amyloidosis and short duration of cytokine release syndrome (CRS), supporting expansion into select immune-mediated diseases. NXC-201 has been awarded Orphan Drug Designation (ODD) in AL Amyloidosis by the US FDA and in the EU by the EMA. Learn more at www.immixbio.com and www.BeProactiveInAL.com.

Apply Now

Share with a friend

Email employer with a question